Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick B Ryan

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
Diabetes Care|June 4, 2025
Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort StudyDaniel R Morales, Fan Bu, Benjamin Viernes, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2025
Comparative Safety of Second-Line Antihyperglycemic Agents in Older Adults with Type 2 Diabetes: A Multinational Real-World Evidence From LEGEND-T2DMChungsoo Kim, Fan Bu, Clair Blacketer, et al.
Cancer Research|September 5, 2019
Recent Developments and Therapeutic Strategies against Hepatocellular CarcinomaMark Yarchoan, Parul Agarwal, Augusto Villanueva, et al.
Scientific Data|April 11, 2024
An open source knowledge graph ecosystem for the life sciencesTiffany J Callahan, Ignacio J Tripodi, Adrianne L Stefanski, et al.
Nature Communications|April 4, 2026
Real-world evidence for comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetesChungsoo Kim, Fan Bu, Clair Blacketer, et al.
NPJ Digital Medicine|May 19, 2023
Ontologizing health systems data at scale: making translational discovery a realityTiffany J Callahan, Adrianne L Stefanski, Jordan M Wyrwa, et al.
Medrxiv : the Preprint Server for Health Sciences|June 27, 2020
Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort studyDaniel R Morales, Mitchell M Conover, Seng Chan You, et al.
Ophthalmology. Retina|March 22, 2024
Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab: An Observational Health Data Sciences and Informatics Network StudyCindy X Cai, Akihiko Nishimura, Mary G Bowring, et al.
The Lancet. Digital Health|December 21, 2020
Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysisDaniel R Morales, Mitchell M Conover, Seng Chan You, et al.
Journal of the American Medical Informatics Association : JAMIA|February 24, 2023
Reproducible variability: assessing investigator discordance across 9 research teams attempting to reproduce the same observational studyAnna Ostropolets, Yasser Albogami, Mitchell Conover, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Diabetes Care|June 4, 2025
Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort StudyDaniel R Morales, Fan Bu, Benjamin Viernes, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2025
Comparative Safety of Second-Line Antihyperglycemic Agents in Older Adults with Type 2 Diabetes: A Multinational Real-World Evidence From LEGEND-T2DMChungsoo Kim, Fan Bu, Clair Blacketer, et al.
Cancer Research|September 5, 2019
Recent Developments and Therapeutic Strategies against Hepatocellular CarcinomaMark Yarchoan, Parul Agarwal, Augusto Villanueva, et al.
Scientific Data|April 11, 2024
An open source knowledge graph ecosystem for the life sciencesTiffany J Callahan, Ignacio J Tripodi, Adrianne L Stefanski, et al.
Nature Communications|April 4, 2026
Real-world evidence for comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetesChungsoo Kim, Fan Bu, Clair Blacketer, et al.
NPJ Digital Medicine|May 19, 2023
Ontologizing health systems data at scale: making translational discovery a realityTiffany J Callahan, Adrianne L Stefanski, Jordan M Wyrwa, et al.
Medrxiv : the Preprint Server for Health Sciences|June 27, 2020
Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort studyDaniel R Morales, Mitchell M Conover, Seng Chan You, et al.
Ophthalmology. Retina|March 22, 2024
Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab: An Observational Health Data Sciences and Informatics Network StudyCindy X Cai, Akihiko Nishimura, Mary G Bowring, et al.
The Lancet. Digital Health|December 21, 2020
Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysisDaniel R Morales, Mitchell M Conover, Seng Chan You, et al.
Journal of the American Medical Informatics Association : JAMIA|February 24, 2023
Reproducible variability: assessing investigator discordance across 9 research teams attempting to reproduce the same observational studyAnna Ostropolets, Yasser Albogami, Mitchell Conover, et al.
Pageof 17